These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 9075114)

  • 1. Preserving the peritoneum in CAPD.
    Medcalf JF; Harris K; Walls J
    Nephrol Dial Transplant; 1997 Mar; 12(3):393-5. PubMed ID: 9075114
    [No Abstract]   [Full Text] [Related]  

  • 2. Peritoneal morphology on maintenance dialysis.
    Pollock CA; Ibels LS; Eckstein RP; Graham JC; Caterson RJ; Mahony JF; Sheil AG
    Am J Nephrol; 1989; 9(3):198-204. PubMed ID: 2667361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peritoneal membrane failure as a determinant of the CAPD future. An epidemiological, functional and pathological study.
    Huarte-Loza E; Selgas R; Carmona AR; Martinez ME; Muñoz J; Fontan MP; Ortega O; Escuin F; Sicilia LS
    Contrib Nephrol; 1987; 57():219-29. PubMed ID: 3677696
    [No Abstract]   [Full Text] [Related]  

  • 4. Morphology of the peritoneum in CAPD.
    Dobbie JW
    Blood Purif; 1989; 7(2-3):74-85. PubMed ID: 2663038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polycystic kidney disease and late peritoneal leakage in CAPD: are they related?
    De V; Scalamogna A; Scanziani R; Castelnovo C; Dozio B; Rovere G
    Perit Dial Int; 2002; 22(1):82-4. PubMed ID: 11929149
    [No Abstract]   [Full Text] [Related]  

  • 6. Longitudinal changes of peritoneal function calculated by personal dialysis capacity in a patient after long-term continuous ambulatory peritoneal dialysis.
    Nakamoto H; Takane H; Sugahara S; Kanno Y; Okada H; Yamamoto T; Suzuki H
    Adv Perit Dial; 2003; 19():97-102. PubMed ID: 14763042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation between peritoneal mesothelial cell cytology and peritoneal histopathology with respect to prognosis in patients on continuous ambulatory peritoneal dialysis.
    Izumotani T; Ishimura E; Yamamoto T; Otoshi T; Okuno S; Inaba M; Kim M; Nishizawa Y
    Nephron; 2001 Sep; 89(1):43-9. PubMed ID: 11528231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peritoneal rest may successfully recover ultrafiltration in patients who develop peritoneal hyperpermeability with time on continuous ambulatory peritoneal dialysis.
    Rodrigues A; Cabrita A; Maia P; Guimarães S
    Adv Perit Dial; 2002; 18():78-80. PubMed ID: 12402593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Laparoscopic Management of Dialysate Leakage Secondary to Necrotic Peritoneum.
    Huang CK; Wang HH; Nor Hanipah Z
    J Laparoendosc Adv Surg Tech A; 2016 Nov; 26(11):921-924. PubMed ID: 27560500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imaging features of encapsulating peritoneal sclerosis in continuous ambulatory peritoneal dialysis patients.
    Ti JP; Al-Aradi A; Conlon PJ; Lee MJ; Morrin MM
    AJR Am J Roentgenol; 2010 Jul; 195(1):W50-4. PubMed ID: 20566781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The peritoneal membrane in chronic peritoneal dialysis.
    Krediet RT
    Kidney Int; 1999 Jan; 55(1):341-56. PubMed ID: 9893150
    [No Abstract]   [Full Text] [Related]  

  • 12. [Type III procollagen N-peptide and hyaluronate in serum and dialysate of CAPD patients].
    Wakabayashi Y; Yamada K; Miura Y; Nakano H; Nishimura M; Tsuchida H; Shigematsu T; Kawaguchi Y; Sakai O
    Nihon Jinzo Gakkai Shi; 1997 May; 39(4):408-13. PubMed ID: 9198363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural and ultrastructural peritoneal membrane changes and permeability alterations during continuous ambulatory peritoneal dialysis.
    Verger C; Brunschvicg O; Le Charpentier Y; Lavergne A; Vantelon J
    Proc Eur Dial Transplant Assoc; 1981; 18():199-205. PubMed ID: 7329968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical characterization of fibroblast subpopulations in normal peritoneal tissue and in peritoneal dialysis-induced fibrosis.
    Jiménez-Heffernan JA; Aguilera A; Aroeira LS; Lara-Pezzi E; Bajo MA; del Peso G; Ramírez M; Gamallo C; Sánchez-Tomero JA; Alvarez V; López-Cabrera M; Selgas R
    Virchows Arch; 2004 Mar; 444(3):247-56. PubMed ID: 14749928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peritoneal dialysis effluent, cytokine levels, and peritoneal mesothelial cell viability in CAPD: a possible relationship.
    Carozzi S; Nasini MG; Ravera M; Sanna A; Tirotta A; Lamperi S
    Adv Perit Dial; 1997; 13():7-12. PubMed ID: 9360642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Permanent loss of ultrafiltration capacity of the peritoneum in long-term peritoneal dialysis: an epidemiological study.
    Slingeneyer A; Canaud B; Mion C
    Nephron; 1983; 33(2):133-8. PubMed ID: 6835460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Persistent transforming growth factor beta 1 expression may predict peritoneal fibrosis in CAPD patients with frequent peritonitis occurrence.
    Lin CY; Chen WP; Fu LW; Yang LY; Huang TP
    Adv Perit Dial; 1997; 13():64-71. PubMed ID: 9360653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Local immunologic reactions induced by CAPD].
    Faller B; Marichal JF; Brignon P
    Nephrologie; 1989; 10 Suppl():30-3. PubMed ID: 2682308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Peritoneal function in CAPD patients].
    Suga H; Ota K
    Nihon Rinsho; 1991 Dec; 49 Suppl():484-91. PubMed ID: 1808305
    [No Abstract]   [Full Text] [Related]  

  • 20. Exfoliated mesothelial cell and CA-125 in automated peritoneal dialysis (APD) and continuous ambulatory peritoneal dialysis (CAPD) patients.
    Kanjanabuch T; Puttipittayathorn N; Leelahavanichkul A; Lieusuwan S; Katavetin P; Mahatanan N; Sriudom K; Chirananthavat T; Thongbor N; Eiam-Ong S
    J Med Assoc Thai; 2011 Sep; 94 Suppl 4():S119-25. PubMed ID: 22043578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.